Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Randomized, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Together With a Randomized Placebo Controlled Double Blind Fermagate Comparison in Hemodialysis Patients With Hyperphosphatemia

NCT00841126 is registered in ClinicalTrials.gov with Ineos Healthcare Limited as lead sponsor.

NCT NCT00841126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Randomized, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Together With a Randomized Placebo Controlled Double Blind Fermagate Comparison in Hemodialysis Patients With Hyperphosphatemia
Lead sponsor
Ineos Healthcare Limited
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2009
Completion date
July 31, 2011
Enrollment
657 (estimated)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure